Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Smart Health Innovation Lab is a market-driven healthcare accelerator that facilitates the validation and adoption of digital health technologies. Established as a joint venture between Penn Medicine Lancaster General Health, Capital Blue Cross, Aspire Ventures, and Clio Health, the lab provides startups with a real-world clinical environment to test their solutions. It offers a certification program designed to integrate new technologies into provider and payer workflows, ensuring they are ready for large-scale deployment. By bridging the gap between health tech developers and healthcare systems, the lab aims to improve patient care and operational efficiency through rigorous testing and market alignment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Smart Health Innovation Lab.